Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis

BACKGROUND: Magnetic resonance imaging (MRI) may guide breast cancer surgery by measuring residual tumor size post-neoadjuvant chemotherapy (NAC). Accurate measurement may avoid overly radical surgery or reduce the need for repeat surgery. This individual patient data (IPD) meta-analysis examines MR...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Autores principales: Marinovich, Michael L., Macaskill, Petra, Irwig, Les, Sardanelli, Francesco, Mamounas, Eleftherios, von Minckwitz, Gunter, Guarneri, Valentina, Partridge, Savannah C., Wright, Frances C., Choi, Jae Hyuck, Bhattacharyya, Madhumita, Martincich, Laura, Yeh, Eren, Londero, Viviana, Houssami, Nehmat
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599727/
https://ncbi.nlm.nih.gov/pubmed/26449630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1664-4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares